Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
3.900
+0.100 (2.63%)
Nov 21, 2024, 1:30 PM EST - Market open
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $41.29 million as of November 21, 2024. Its market cap has increased by 1,690.96% in one year.
Market Cap
41.29M
Enterprise Value
35.64M
1-Year Change
1,690.96%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has increased from $16.38M to $41.29M, an increase of 152.06%. That is a compound annual growth rate of 52.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 41.08M | 1,264.50% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daxor | 43.56M |
| Achilles Therapeutics | 42.73M |
| Omega Therapeutics | 42.66M |
| Accelerate Diagnostics | 42.62M |
| iCAD, Inc. | 42.43M |
| LAVA Therapeutics | 42.34M |
| HCW Biologics | 41.99M |
| CERo Therapeutics Holdings | 41.65M |